New York Life Investment Management »

Sana Biotechnology shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $431k 106k 4.08
2023-09-30 $421k 109k 3.87
2023-06-30 $751k 126k 5.96
2023-03-31 $472k 145k 3.27

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Sana Biotechnology

Flagship Ventures Management
Baillie Gifford & Co
Vanguard Group
T. Rowe Price Associates
Crestline Management
Alphabet
Millennium Management
Baker Bros. Advisors
Partner Fund Management
Jpmorgan Chase & Co
Massachusetts Financial Services
Omega Fund Management
Goldman Sachs Group
Charles Schwab Investment Management
Arrowpoint Asset Management

View all funds holding Sana Biotechnology